The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Encephalitis Vaccine Market Research Report 2024

Global Encephalitis Vaccine Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1414014

No of Pages : 92

Ask Your Query

Synopsis

Encephalitis Vaccination is an effective measure for the prevention of epidemic encephalitis. It is by yellow virus arboviruses - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito’s classes. People and many animals may be infection source after infection Encephalitis virus.

The global Encephalitis Vaccine market was valued at US$ 1291.2 million in 2023 and is anticipated to reach US$ 1905.8 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Encephalitis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Encephalitis Vaccine.

Report Scope

The Encephalitis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Encephalitis Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Encephalitis Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company (Partial List)

  • Valneva
  • Sanofi Pasteur
  • Biken
  • Wuhan Institute of Biological Products
  • Lanzhou Institute of Biological Products
  • Chengdu Institute of Biological Products
  • Tiantan Biological Products
  • Liaoning Chengda
  • Zhejiang Tianyuan Bio-Pharmaceutical
  • Yisheng Bio
  • Changchun Institute of Biological Products

Segment by Type

  • Inactivated Vaccine
  • Live Attenuated Vaccine

Segment by Application

  • Child
  • Adult

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Encephalitis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Encephalitis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Encephalitis Vaccine Market Overview
1.1 Product Overview and Scope of Encephalitis Vaccine
1.2 Encephalitis Vaccine Segment by Type
1.2.1 Global Encephalitis Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Inactivated Vaccine
1.2.3 Live Attenuated Vaccine
1.3 Encephalitis Vaccine Segment by Application
1.3.1 Global Encephalitis Vaccine Market Value by Application: (2024-2030)
1.3.2 Child
1.3.3 Adult
1.4 Global Encephalitis Vaccine Market Size Estimates and Forecasts
1.4.1 Global Encephalitis Vaccine Revenue 2019-2030
1.4.2 Global Encephalitis Vaccine Sales 2019-2030
1.4.3 Global Encephalitis Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Encephalitis Vaccine Market Competition by Manufacturers
2.1 Global Encephalitis Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Encephalitis Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Encephalitis Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Encephalitis Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Encephalitis Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Encephalitis Vaccine, Product Type & Application
2.7 Encephalitis Vaccine Market Competitive Situation and Trends
2.7.1 Encephalitis Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Encephalitis Vaccine Players Market Share by Revenue
2.7.3 Global Encephalitis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Encephalitis Vaccine Retrospective Market Scenario by Region
3.1 Global Encephalitis Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Encephalitis Vaccine Global Encephalitis Vaccine Sales by Region: 2019-2030
3.2.1 Global Encephalitis Vaccine Sales by Region: 2019-2024
3.2.2 Global Encephalitis Vaccine Sales by Region: 2025-2030
3.3 Global Encephalitis Vaccine Global Encephalitis Vaccine Revenue by Region: 2019-2030
3.3.1 Global Encephalitis Vaccine Revenue by Region: 2019-2024
3.3.2 Global Encephalitis Vaccine Revenue by Region: 2025-2030
3.4 North America Encephalitis Vaccine Market Facts & Figures by Country
3.4.1 North America Encephalitis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Encephalitis Vaccine Sales by Country (2019-2030)
3.4.3 North America Encephalitis Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Encephalitis Vaccine Market Facts & Figures by Country
3.5.1 Europe Encephalitis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Encephalitis Vaccine Sales by Country (2019-2030)
3.5.3 Europe Encephalitis Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Encephalitis Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Encephalitis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Encephalitis Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Encephalitis Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Encephalitis Vaccine Market Facts & Figures by Country
3.7.1 Latin America Encephalitis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Encephalitis Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Encephalitis Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Encephalitis Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Encephalitis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Encephalitis Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Encephalitis Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Encephalitis Vaccine Sales by Type (2019-2030)
4.1.1 Global Encephalitis Vaccine Sales by Type (2019-2024)
4.1.2 Global Encephalitis Vaccine Sales by Type (2025-2030)
4.1.3 Global Encephalitis Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Encephalitis Vaccine Revenue by Type (2019-2030)
4.2.1 Global Encephalitis Vaccine Revenue by Type (2019-2024)
4.2.2 Global Encephalitis Vaccine Revenue by Type (2025-2030)
4.2.3 Global Encephalitis Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Encephalitis Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Encephalitis Vaccine Sales by Application (2019-2030)
5.1.1 Global Encephalitis Vaccine Sales by Application (2019-2024)
5.1.2 Global Encephalitis Vaccine Sales by Application (2025-2030)
5.1.3 Global Encephalitis Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Encephalitis Vaccine Revenue by Application (2019-2030)
5.2.1 Global Encephalitis Vaccine Revenue by Application (2019-2024)
5.2.2 Global Encephalitis Vaccine Revenue by Application (2025-2030)
5.2.3 Global Encephalitis Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Encephalitis Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Valneva
6.1.1 Valneva Corporation Information
6.1.2 Valneva Description and Business Overview
6.1.3 Valneva Encephalitis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Valneva Encephalitis Vaccine Product Portfolio
6.1.5 Valneva Recent Developments/Updates
6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur Corporation Information
6.2.2 Sanofi Pasteur Description and Business Overview
6.2.3 Sanofi Pasteur Encephalitis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Pasteur Encephalitis Vaccine Product Portfolio
6.2.5 Sanofi Pasteur Recent Developments/Updates
6.3 Biken
6.3.1 Biken Corporation Information
6.3.2 Biken Description and Business Overview
6.3.3 Biken Encephalitis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Biken Encephalitis Vaccine Product Portfolio
6.3.5 Biken Recent Developments/Updates
6.4 Wuhan Institute of Biological Products
6.4.1 Wuhan Institute of Biological Products Corporation Information
6.4.2 Wuhan Institute of Biological Products Description and Business Overview
6.4.3 Wuhan Institute of Biological Products Encephalitis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Wuhan Institute of Biological Products Encephalitis Vaccine Product Portfolio
6.4.5 Wuhan Institute of Biological Products Recent Developments/Updates
6.5 Lanzhou Institute of Biological Products
6.5.1 Lanzhou Institute of Biological Products Corporation Information
6.5.2 Lanzhou Institute of Biological Products Description and Business Overview
6.5.3 Lanzhou Institute of Biological Products Encephalitis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Lanzhou Institute of Biological Products Encephalitis Vaccine Product Portfolio
6.5.5 Lanzhou Institute of Biological Products Recent Developments/Updates
6.6 Chengdu Institute of Biological Products
6.6.1 Chengdu Institute of Biological Products Corporation Information
6.6.2 Chengdu Institute of Biological Products Description and Business Overview
6.6.3 Chengdu Institute of Biological Products Encephalitis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Chengdu Institute of Biological Products Encephalitis Vaccine Product Portfolio
6.6.5 Chengdu Institute of Biological Products Recent Developments/Updates
6.7 Tiantan Biological Products
6.6.1 Tiantan Biological Products Corporation Information
6.6.2 Tiantan Biological Products Description and Business Overview
6.6.3 Tiantan Biological Products Encephalitis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Tiantan Biological Products Encephalitis Vaccine Product Portfolio
6.7.5 Tiantan Biological Products Recent Developments/Updates
6.8 Liaoning Chengda
6.8.1 Liaoning Chengda Corporation Information
6.8.2 Liaoning Chengda Description and Business Overview
6.8.3 Liaoning Chengda Encephalitis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Liaoning Chengda Encephalitis Vaccine Product Portfolio
6.8.5 Liaoning Chengda Recent Developments/Updates
6.9 Zhejiang Tianyuan Bio-Pharmaceutical
6.9.1 Zhejiang Tianyuan Bio-Pharmaceutical Corporation Information
6.9.2 Zhejiang Tianyuan Bio-Pharmaceutical Description and Business Overview
6.9.3 Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Product Portfolio
6.9.5 Zhejiang Tianyuan Bio-Pharmaceutical Recent Developments/Updates
6.10 Yisheng Bio
6.10.1 Yisheng Bio Corporation Information
6.10.2 Yisheng Bio Description and Business Overview
6.10.3 Yisheng Bio Encephalitis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Yisheng Bio Encephalitis Vaccine Product Portfolio
6.10.5 Yisheng Bio Recent Developments/Updates
6.11 Changchun Institute of Biological Products
6.11.1 Changchun Institute of Biological Products Corporation Information
6.11.2 Changchun Institute of Biological Products Encephalitis Vaccine Description and Business Overview
6.11.3 Changchun Institute of Biological Products Encephalitis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Changchun Institute of Biological Products Encephalitis Vaccine Product Portfolio
6.11.5 Changchun Institute of Biological Products Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Encephalitis Vaccine Industry Chain Analysis
7.2 Encephalitis Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Encephalitis Vaccine Production Mode & Process
7.4 Encephalitis Vaccine Sales and Marketing
7.4.1 Encephalitis Vaccine Sales Channels
7.4.2 Encephalitis Vaccine Distributors
7.5 Encephalitis Vaccine Customers
8 Encephalitis Vaccine Market Dynamics
8.1 Encephalitis Vaccine Industry Trends
8.2 Encephalitis Vaccine Market Drivers
8.3 Encephalitis Vaccine Market Challenges
8.4 Encephalitis Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock